Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Penn National's theScore Bet Inks 10-Year Gaming Partnership With Toronto Blue Jays

theScore Bet, a wholly-owned subsidiary of Penn National Gaming Inc (NASDAQ:PENN), and the Toronto Blue Jays baseball team have signed a ten-year exclusive partnership. theScore Bet has become the gaming partner of the Toronto Blue Jays. The move comes as Ontario recently opened its market for sports betting and iGaming to regulated private…

10 Information Technology Stocks Whale Activity In Today's Session

10 Information Technology Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Weibo Plays With the Big Boys in Numbers, But Investors Still Worry

Key takeaways: Weibo’s revenue rose above pre-pandemic levels last year, but its profitability lagged due to heavy spending The company trails Meta in its ability to monetize users, and is very much in the shadow of local rival WeChat in terms of total user numbers By Ken Lo

Read How Analysts Reacted To Simply Good Foods' Q2 Results

Citi analyst Wendy Nicholson raised the price target on Simply Good Foods Co (NASDAQ: SMPL) to $48 from $46 (15% upside) and kept a Buy rating on the shares.

After Tequila, Belt Buckles And Flamethrowers, Could This Be The Next Great Tesla Novelty Item?

Tesla Inc (NASDAQ: TSLA) has a huge fan base that has helped the company succeed and grow its sales and market share over the years.

Google In 1996, Apple In 2010: What Does The 14-Year Investment Thesis Mean For Crypto In 2024?

Mark Yusko, founder, CIO and CEO of Morgan Creek Capital Management, explained how he gained his experience in the world of investing on Benzinga's podcast "The Long Run Show."

inkl

Read news from The Economist, FT, and more,
with one subscription

Cambridge Q1 2022 Earnings Conference Call On April 20, 2022 At 11:00 AM ET

Cambridge Q1 2022 Earnings Conference Call On April 20, 2022 At 11:00 AM ET

Cambridge (NASDAQ:CATC) will host a conference call at 11:00 AM ET on April 20, 2022, to discuss Q1 2022 earnings results.

Stocks That Hit 52-Week Highs On Thursday

Stocks That Hit 52-Week Highs On Thursday

On Thursday, 75 stocks made new 52-week highs.

Recap: Northern Technologies Q2 Earnings

Recap: Northern Technologies Q2 Earnings

Northern Technologies (NASDAQ:NTIC) reported its Q2 earnings results on Thursday, April 7, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

WKSP: April Update

By Thomas Kerr, CFA NASDAQ:WKSP READ THE FULL WKSP RESEARCH REPORT

38 Stocks Moving In Thursday's Mid-Day Session

38 Stocks Moving In Thursday's Mid-Day Session

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.

What Is PayPal 3.0 — And How Does It Affect Investors?

What Is PayPal 3.0 — And How Does It Affect Investors?

PayPal Holdings Inc (NASDAQ: PYPL) is undertaking several growth initiatives that could shape its future, according to BofA Securities. The PayPal Holdings Analyst: Jason Kupferberg maintained a Neutral rating on PayPal Holdings, with an unchanged price target of $118.

What Are Whales Doing With Moderna

What Are Whales Doing With Moderna

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Get all your
news in one place.

100's of premium titles.
One news app.

This Is What Whales Are Betting On Tesla

A whale with a lot of money to spend has taken a noticeably bearish stance on Tesla. Looking at options history for Tesla (NASDAQ:TSLA) we detected 596 strange trades.

Analysts Bump Up Costco Price Target Post March Sales Results

Truist analyst Scot Ciccarelli raised the price target on Costco Wholesale Corp (NASDAQ: COST) to $634 from $603 and kept a Buy rating on the shares.

How Is The Market Feeling About Regeneron Pharmaceuticals Inc?

Regeneron Pharmaceuticals Inc's (NASDAQ:REGN) short percent of float has risen 4.85% since its last report. The company recently reported that it has 2.24 million shares sold short, which is 2.16% of all regular shares that are available for trading.

Looking Into Momentus Inc. - Class A Common Stock's Recent Short Interest

Momentus Inc. - Class A Common Stock's (NASDAQ:MNTS) short percent of float has risen 19.09% since its last report. The company recently reported that it has 2.53 million shares sold short, which is 4.99% of all regular shares that are available for trading.

Get all your
news in one place.

100's of premium titles.
One news app.

Insurance Stocks Moving In Thursday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

FDA Places Partial Hold On Vadadustat Pediatric Studies, Akebia Cuts Over 40% Staff

Battered after a surprising FDA rejection for its lead pipeline program last week, Akebia Therapeutics Inc (NASDAQ:AKBA) has layoffs that are now on the way. In a filing with the SEC, Akebia said the FDA issued a partial clinical hold on the drug's pediatric studies. As a result, Akebia will suspend all vadadustat studies…

Mid-Day Market Update: Dow Tumbles Over 200 Points; Momentus Shares Jump

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Thursday.

AstraZeneca Bets $25M On Preclinical Bispecific Antibody

Harbour BioMed has announced a global out-license agreement with AstraZeneca plc (NASDAQ:AZN) for CLDN18.2xCD3 bispecific antibody (HBM7022). HBM7022 is a novel bispecific antibody generated from HBM's HCAb Based Immune Cell Engagers (HBICE) Platform. HBM7022 is currently in the preclinical stage, which crosslinks tumor cells and T cells by targeting a tumor-associated antigen (Claudin18.2) and…

Trevi Therapeutics Shares Gain On Raising $55M Via Equity

Trevi Therapeutics Inc (NASDAQ: TRVI) has announced a private placement of 4.5 million priced at $1.90 per share and pre-funded warrants to purchase up to 24.4 million shares at $1.899 per warrant.

AngioDynamics Posts Wider Q3 Loss On Higher Costs, Reaffirms FY22 Outlook

AngioDynamics Inc (NASDAQ:ANGO) has reported a Q3 FY22 adjusted EPS of $0.03, ahead of the consensus of $(0.01), and better than the consensus of $0.02 reported a year ago. Q3 sales increased 3.9% Y/Y to $73.97 million, missing the analyst consensus of $76.32 million. Endovascular Therapies net sales increased 14.5% to $38.1…

JPMorgan Chase Partners With EVgo To Install EV Charging Stations

Chase, the U.S. consumer and commercial banking business of JPMorgan Chase & Co (NYSE:JPM), has partnered with EVgo Inc (NASDAQ:EVGO) to install charging stations. Chase will pilot public fast electric vehicle charging stations across 50 of its U.S. branches beginning in the summer of 2022. The move will support the firm’s aim to expand on-site solar…

1 … 716 717 718 719

People

Jason Kupferberg

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

366,520 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play